• Online Features  This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (11)  • Contact me when this article is cited  Related Content  • Related articles  • Similar articles in this journal  Topic Collections  • Oncology  • Skin Cancer  • Dermatology  • Dermatologic Disorders  • Neoplasms  • Screening  • Alert me on articles by topic  Social Bookmarking   What's this?

Focusing the Public Health Journey

Howard K. Koh, MD, MPH

Arch Dermatol. 2007;143(1):101-103.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In the 1970s, with rising melanoma incidence and mortality rates, some investigators conducted isolated skin cancer screening efforts as a strategy for early detection.^1-3 Intrigued by the appeal of visual examination as a potentially effective screening tool, others then joined in. In the 1980s and 1990s, growing numbers of dermatology-led skin cancer screening clinics nationwide prompted more systematic investigations into the complex public health dimensions involved.^4-8 Some proposed targeting higher-risk populations for special consideration. Others probed self-screening as a potential tool.^8-10 Teams from Australia and elsewhere contributed their expertise,^11-12 in particular, addressing issues of screening by general practitioners. International organizations began to weigh the general advisability of melanoma screening as part of broader cancer screening policy.^{7, 13-14} Despite these decades of research, practice, and inquiry, consensus about melanoma screening remains elusive. In the 21st century, how will this public health journey progress?

Screening seems easy, but . . . [Full Text of this Article]

AUTHOR INFORMATION


CiteULike    Connotea    Delicious    Digg    Facebook    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLES

Visual Screening for Malignant Melanoma: A Cost-effectiveness Analysis
Elena Losina, Rochelle P. Walensky, Alan Geller, Frederick C. Beddingfield, III, Lindsey L. Wolf, Barbara A. Gilchrest, and Kenneth A. Freedberg
Arch Dermatol. 2007;143(1):21-28.
ABSTRACT | FULL TEXT  

Effect of Health Care Delivery Models on Melanoma Thickness and Stage in a University-Based Referral Center: An Observational Pilot Study
Susan M. Swetter, Seaver Soon, Cynthia R. Harrington, and Suephy C. Chen
Arch Dermatol. 2007;143(1):30-36.
ABSTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The Influence of Age and Sex on Reasons for Seeking and Expected Benefits of Skin Cancer Screening
Andrulonis et al.
Arch Dermatol 2010;146:1097-1102.
ABSTRACT | FULL TEXT  

Routine Dermatologist-Performed Full-Body Skin Examination and Early Melanoma Detection
Kantor and Kantor
Arch Dermatol 2009;145:873-876.
ABSTRACT | FULL TEXT  

Survival Differences Between Patients With Scalp or Neck Melanoma and Those With Melanoma of Other Sites in the Surveillance, Epidemiology, and End Results (SEER) Program
Lachiewicz et al.
Arch Dermatol 2008;144:515-521.
ABSTRACT | FULL TEXT